CliffBio
small molecule

QUTENZA

CAPSAICIN

Loss of exclusivityMarch 2030latest FDA-listed patent expiry
CompanyAVERITAS PHARMA INC →View the full company profile on CliffBio

Drug detail

Brand nameQUTENZA
Active ingredientCAPSAICIN
Strength8%
Dosage formPATCH
RouteTOPICAL
ModalitySmall molecule
FDA approvalNovember 2009
Marketing statusRX

Listed patents

PatentExpiresType
8821920March 2030product
9226903December 2028product

More from AVERITAS PHARMA INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

QUTENZA patent cliff — loss of exclusivity March 2030 | CliffBio